Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
ELOX was delisted on the 13th of October, 2023.
40 hedge funds and large institutions have $91.3M invested in Eloxx Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$27.8M |
| 2 |
BlackRock
New York
|
+$17M |
| 3 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$8.69M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.68M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.33M |
Top Sellers
ELOX Hedge Fund Activity: Q2 2018 in Review
40 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) for Q2 2018, worth a combined $91.3M.
Buyers outnumbered sellers: 40 funds opened new ELOX positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Menora Mivtachim Holdings, opening a new position worth an estimated $27.8M.
- 40 institutional investors held Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $91.3M of Eloxx Pharmaceuticals, Inc. Common Stock stock for Q2 2018.
- 40 funds opened new Eloxx Pharmaceuticals, Inc. Common Stock positions in Q2 2018 and 0 closed out, a net change of +40 holders.
- The largest Eloxx Pharmaceuticals, Inc. Common Stock buyer in Q2 2018 was Menora Mivtachim Holdings, an estimated $27.8M added.
Based on aggregated 13F filings for Q2 2018.